CN104666889A - Anti-tumor traditional Chinese medicine - Google Patents

Anti-tumor traditional Chinese medicine Download PDF

Info

Publication number
CN104666889A
CN104666889A CN201310630211.9A CN201310630211A CN104666889A CN 104666889 A CN104666889 A CN 104666889A CN 201310630211 A CN201310630211 A CN 201310630211A CN 104666889 A CN104666889 A CN 104666889A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
radix astragali
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201310630211.9A
Other languages
Chinese (zh)
Inventor
赖虹杜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Health And Happiness Chinese Medicine Health Preserving Academy
Original Assignee
Shaanxi Health And Happiness Chinese Medicine Health Preserving Academy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Health And Happiness Chinese Medicine Health Preserving Academy filed Critical Shaanxi Health And Happiness Chinese Medicine Health Preserving Academy
Priority to CN201310630211.9A priority Critical patent/CN104666889A/en
Publication of CN104666889A publication Critical patent/CN104666889A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an anti-tumor traditional Chinese medicine. The traditional Chinese medicine comprises 6-10 parts of radix astragali, 11-15 parts of ginseng, 6-9 parts of Chinese caterpillar fungus, 8-13 parts of lucid ganoderma, 15-25 parts of barbed skullcap herb, 10-25 parts of spreading hedyotis herb, 6-10 parts of dried tangerine peel, 6-10 parts of fragrant solomonseal rhizome and 6-10 parts of glossy privet fruit. The traditional Chinese medicine is jointly prepared from the following traditional Chinese medicine active pharmaceutical ingredients in parts by weight: 8 parts of radix astragali, 12 parts of ginseng, 8 parts of Chinese caterpillar fungus, 12 parts of lucid ganoderma, 20 parts of barbed skullcap herb, 20 parts of spreading hedyotis herb, 8 parts of dried tangerine peel, 8 parts of fragrant solomonseal rhizome and 8 parts of glossy privet fruit. The traditional Chinese medicine utilizes the traditional Chinese medicine and modern preparation technology and has the effects of overcoming the defects existing when malignant tumors are treated with western medicines, improving the immunities of patients, reinforcing the vital energy and consolidating the constitution, inhibiting regeneration of cancer cells and effectively lengthening the survival time of the cancer cells.

Description

A kind of antineoplastic Chinese medicine
Technical field
The present invention relates to a kind of antineoplastic Chinese medicine.
Background technology
Motherland's medical science without " tumor " name of disease, tumor many due to chronic dietary do not save, disorder of emotion, overstrain internal injury or experience external evil poison, cause body imbalance between YIN and YANG, zang-fu differentiation malfunction, with the passing of time deficiency of qi and blood; It is unable that the deficiency of vital energy then promotes blood, and then occur blood stasis; In addition accumulate in evil poison, finally cause cancerous protuberance to be formed.As Jing-Yue Complete Works is said: " tripe fu jie block, blood that must be tangible ", illustrate that the disease gathered can be sent out because of deficient, tripe fu jie block, also can be tied by blood stasis.Studying carefully its pathogenesis is weakness of the spleen and stomach, deficiency of both QI and blood, and ecchymosis is tied mutually, stagnant caused by the stomach network.Its pathogenesis key is " void ", " stasis of blood ", " poison ".
Under current China treatment level and condition, during most of malignant tumor patient is made a definite diagnosis and is belonged to, late case, and the transfer of adjoint tumor, current essential therapeutic arsenals is chemotherapy, radiotherapy, operation, but not every conditions of patients can be applicable to above-mentioned three kinds of means, especially chemoradiotherapy toxic and side effects is obvious for above-mentioned means simultaneously; This present situation impels people actively to find from natural medicinal plants, seek drug effect clear and definite but the new way that toxic and side effects is relatively few or medicine, patient is caused not damage under body healthy energy and immune functional state, eliminate the cancer of local as far as possible, play the effect for the treatment of tumor, extend the life span of patient.
Application number is that in the patent of 201110360471.X, the Coleus forskohlii Briq. place of production is at the Southeast Asia such as India one band, and medical material not easily obtains.The present invention adds the medical material such as Rhizoma Polygonati Odorati, Fructus Ligustri Lucidi on the basis of this patent, improves drug effect, and selected medical material is easy to get at home.
Summary of the invention
The invention provides a kind of antineoplastic Chinese medicine, utilize Chinese medicine and Modern preparations technology, overcome the defect of western medical treatment malignant tumor, improve patient's immunity, strengthening the body resistance, anticancer regenerates, and effectively extends their life span.
For this reason, the invention provides following Chinese medicine: comprise Radix Astragali 6-10 part, Radix Ginseng 11-15 part, Cordyceps 6-9 part, Ganoderma 8-13 part, Herba Scutellariae Barbatae 15-25 part, Hedyotidis Diffusae 10-25 part, Pericarpium Citri Reticulatae 6-10 part, Rhizoma Polygonati Odorati 6-10 part, Fructus Ligustri Lucidi 6-10 part.
Above-mentioned Chinese medicine is formed by following weight parts raw material of Chinese medicine medicine system of closing: the Radix Astragali 8 parts, Radix Ginseng 12 parts, Cordyceps 8 parts, Ganoderma 12 parts, Herba Scutellariae Barbatae 20 parts, Hedyotidis Diffusae 20 parts, Pericarpium Citri Reticulatae 8 parts, Rhizoma Polygonati Odorati 8 parts, Fructus Ligustri Lucidi 8 parts.
Medical material selected by the present invention and pharmacology as follows:
The Radix Astragali: sweet, tepor.Return lung, spleen, liver, kidney channel.Weak for the deficiency of vital energy, fatigue and weakness, or sinking of QI of middle-JIAO, proctoptosis, uterine prolapse.
Radix Ginseng: sweet, micro-hardship, tepor.Strongly invigorating primordial QI, spleen invigorating lung benefiting, promoting the production of body fluid and inducing sedation of the mind.Its antineoplastic action mechanism of the heterogeneity of ginsenoside is different.Prostisol in Radix Ginseng, has the effect promoting the synthesis of ribonucleic acid, protein, lipids, biological, improves the immunity of body, has auxiliaring effect to the treatment of cancer.
Cordyceps: sweet, temperature.Kidney tonifying tonifying the lung, hemostasis and phlegm.Cordycepin contained by Cordyceps can suppress the nucleic acid of the cell line of mouse leukemia L5187 to synthesize; Thus attack tumor cell, play active anticancer.
Ganoderma: sweet, tepor.Invigorating middle warmer kidney tonifying, tranquilizing by nourishing the heart.The fibrosarcoma of Ganoderma mycelium extract to mouse subcutaneous transplanting has obvious Developing restraint effect, and also has inhibitory action to pulmonary's metastasis of fibrosarcoma, has obvious cytotoxic activity to P3HR-1 and CIT26-P3 tumor cell strain.
Herba Scutellariae Barbatae: heat clearing away, removing toxic substances, dissipating blood stasis, hemostasis, inducing diuresis to remove edema, analgesic therapy.Herba Scutellariae Barbatae reaches 100% to JTc-26 oncocyte extracorporeal inhibiting rate, and it is then only 50% to Normocellular suppression ratio.Finding when observing the clinical antineoplastic curative effect of these Chinese medicines, even the late tumor to the weary art for the treatment of, being also improved symptom, Tumor suppression propagation and extending the effect of patient vitals.
Hedyotidis Diffusae: mildly bitter flavor, sweet, cold.Enter stomach, large intestine, small intestine meridian, clearing up internal heat by using drugs of bitter in taste and cold in nature detoxifies, and sweet cold eliminating damp-heat, has stronger removing toxicity for eliminating carbuncles effect to carbuncle, pharyngalgia, snakebite etc.
Pericarpium Citri Reticulatae: effect of appetizing in tool regulating QI and lowering the adverseness, tune, drying dampness to eliminate phlegm.
Rhizoma Polygonati Odorati: sweet, flat.Nourishing YIN and moistening the lung, nourishing the stomach of promoting the production of body fluid.Rhizoma Polygonati Odorati can improve body's immunity, suppresses the growth of carcinoma; Its water extract experiment in vitro has inhibit activities to human cervical carcinoma JTC26 cell.In addition, this product also has heart tonifying, regulates blood pressure, increases coronary flow, blood fat reducing, atherosclerosis and the effect such as antibacterial.
Fructus Ligustri Lucidi: sweet is bitter, cool.Liver and kidney tonifying, clearing away heat to improve acuity of vision.Fructus Ligustri Lucidi water extract can significantly improve the immunologic function of body to tumor.The sudden change that Fructus Ligustri Lucidi brings out cyclophosphamide, urethane and cell chromosome damage all have inhibitory action, and prompting has anti-cancer active.Rising effect is had to because of chemotherapy and caused by radiation leukopenia.
The present invention's growth of cancer cells speed after patients with lung cancer is taken slows down, and convenient oral, improves symptom.
Detailed description of the invention
Embodiment 1:
Filter out the Radix Astragali 8 parts, Radix Ginseng 12 parts, Cordyceps 8 parts, Ganoderma 12 parts, Herba Scutellariae Barbatae 20 parts, Hedyotidis Diffusae 20 parts, Pericarpium Citri Reticulatae 8 parts, Rhizoma Polygonati Odorati 8 parts, Fructus Ligustri Lucidi 8 parts, drying and crushing crosses 120 mesh sieves, makes capsule, each six, every day twice.
Embodiment 2:
Filter out yellow Herba Selaginellae 30 parts, Radix Sanguisorbae 15 parts, 30 parts, the Radix Rehmanniae, 15 parts, Radix Rehmanniae Preparata, Herba Scutellariae Barbatae 25 parts, Scorpio 9 parts, 20 parts, Nidus Vespae, Cordyceps 22 parts, Placenta Hominis 12 parts.After water extraction, under 60 DEG C of conditions, microwave drying must extract dry thing, and drying and crushing crosses 120 mesh sieves, adds Mel and makes big honeyed pills agent, each two balls, every day twice.
clinical experiment is observed:
(1) Therapeutic Method:
Pre-clinical research is carried out on zooperal basis: under the proper intensive care of doctor, instruct aspiration pill taker to try out.
Choose 120 routine cancer sufferers in mid-term, 30 examples (treatment group 1) take the medicine of the embodiment of the present invention 1 while chemotherapy; 30 examples (treatment group 2) take the medicine of the embodiment of the present invention 2 while chemotherapy; 30 examples (matched group 1) only carry out chemotherapeutic treatment; 30 examples (matched group 2) do not do any treatment.This clinical trial phase is 3 months.
(2) efficacy assessment standard:
Effective: tumor cell reproduction speed obviously slows down, patient's appetite increases progressively, and body weight increases;
Effective: tumor cell growth rate slows down, normal cell reproduction speed is slow, and immunity is still low;
Invalid: symptom does not have sluggish trend or tumor cell to worsen further compared with before treatment.
(3) therapeutic outcome is as following table:
Effective (people) Effectively (people) Invalid (people) Effective percentage
Treatment group 1 15 12 3 90%
Treatment group 2 16 12 2 93%
Matched group 1 15 11 4 87%
Matched group 2 - - 30 -

Claims (2)

1. an antineoplastic Chinese medicine, is characterized in that: the present invention comprises Radix Astragali 6-10 part, Radix Ginseng 11-15 part, Cordyceps 6-9 part, Ganoderma 8-13 part, Herba Scutellariae Barbatae 15-25 part, Hedyotidis Diffusae 10-25 part, Pericarpium Citri Reticulatae 6-10 part, Rhizoma Polygonati Odorati 6-10 part, Fructus Ligustri Lucidi 6-10 part.
2. antineoplastic Chinese medicine according to claim 1, is characterized in that: it is formed by following weight parts raw material of Chinese medicine medicine system of closing: the Radix Astragali 8 parts, Radix Ginseng 12 parts, Cordyceps 8 parts, Ganoderma 12 parts, Herba Scutellariae Barbatae 20 parts, Hedyotidis Diffusae 20 parts, Pericarpium Citri Reticulatae 8 parts, Rhizoma Polygonati Odorati 8 parts, Fructus Ligustri Lucidi 8 parts.
CN201310630211.9A 2013-12-02 2013-12-02 Anti-tumor traditional Chinese medicine Withdrawn CN104666889A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310630211.9A CN104666889A (en) 2013-12-02 2013-12-02 Anti-tumor traditional Chinese medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310630211.9A CN104666889A (en) 2013-12-02 2013-12-02 Anti-tumor traditional Chinese medicine

Publications (1)

Publication Number Publication Date
CN104666889A true CN104666889A (en) 2015-06-03

Family

ID=53302825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310630211.9A Withdrawn CN104666889A (en) 2013-12-02 2013-12-02 Anti-tumor traditional Chinese medicine

Country Status (1)

Country Link
CN (1) CN104666889A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107468871A (en) * 2017-09-27 2017-12-15 张存法 A kind of Chinese medicine composition for treating tumour and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107468871A (en) * 2017-09-27 2017-12-15 张存法 A kind of Chinese medicine composition for treating tumour and preparation method thereof

Similar Documents

Publication Publication Date Title
CN105920085B (en) Composition with attenuation effect and preparation method and application thereof
CN101181529B (en) Chinese medicine composition for curing tumor and preparation method thereof
CN103784802B (en) A kind of Chinese medicine composition for the treatment of diabetes
CN102988821B (en) Chinese medicine composition for treating carcinomatosis postoperation, postchemotherapy and postradiotherapy and preparation method of Chinese medicine composition
CN103861079B (en) Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors
CN1994455A (en) Enteric coated Chinese medicinal capsule for treating cancer and preparation method thereof
CN104083560A (en) Traditional Chinese medicine for treating cancer related anemia
CN101711848B (en) Chinese medicinal composition capable of adjunctively treating tumour
CN105327218A (en) Spleen and stomach strengthening pill for children and preparation method thereof
CN102526498A (en) Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof
CN101518594B (en) Anti-tumor immunity-enhancing traditional Chinese medicine preparation and preparation method thereof
CN101209334B (en) Lung cancer-treating medicament and preparation thereof
CN104352603A (en) Anti-tumor traditional Chinese medicine capable of enhancing immunity of human body
CN104666889A (en) Anti-tumor traditional Chinese medicine
CN104398920B (en) A kind of drug and preparation method thereof for consolidating irradiation for cervical cancer effect
CN102861236A (en) Anti-tumor preparation made of pure traditional Chinese medicines
CN105902897A (en) Pharmaceutical preparation for treating pancreatic cancer and application thereof
CN102626509B (en) Traditional Chinese medicine composite for curing pediatric jaundice
CN104587300A (en) Traditional Chinese medicine composition for treating acute leukemia and preparation method of traditional Chinese medicine composition
CN104306847A (en) Six-ingredient qi-tonifying capsule and preparation process thereof
CN103495103A (en) Medicament for promoting digestion and strengthening spleen
CN103007145A (en) Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition
CN102100814A (en) Method for preparing nanometer traditional Chinese medicine for treating severe asthma and production method thereof
CN101224295A (en) Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof
CN104857276A (en) Traditional Chinese medicine for treating both qi and yin deficiency caused by radiotherapy-chemotherapy for malignant tumor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication

Application publication date: 20150603